RxDoctor Payments DataLook up a doctor →

Michael Grossman, DPM

Podiatrist · Bala Cynwyd, PANPI 1225011786

Payments from drug & device makers

$8,814in general payments, 2019–2025

Across 219 payments — averaging $40.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$2K
  • Smith+Nephew$1K
  • Treace Medical Concepts, Inc.$802
  • Liberty Surgical Inc.$758
  • Stryker$697
  • Integra Lifesciences Corporation$552
  • plus $3K from 29 others

What the payments were for

  • Speaking & faculty fees$2433%
  • Food & beverage$7,81389%
  • Education$7589%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,814 in reported general payments places this provider in the 90th percentile of 445 podiatrist providers in Pennsylvania.

See all podiatrist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,112,863
Medicare patients
948
Services billed
6,384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate25$617
Ketoconazole28$583
Clobetasol Propionate12$367
Amlodipine Besylate13$300
Mupirocin15$117
Naproxen24$78
Quetiapine Fumarate13$77
Cephalexin13$71
Furosemide18$64
Prednisone20$59

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bala Cynwyd

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →